BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Product: Human albumin

Presentation	Product	Chemical substance	Chapter	Items dispensed
Albumin human 20% solution for infusion 100ml bottles 0902022A0AAACAC	Human albumin	Albumin solution	Nutrition and Blood	No data available
Albumin human 20% solution for infusion 50ml bottles 0902022A0AAABAB	Human albumin	Albumin solution	Nutrition and Blood	No data available
Albumin human 4.5% solution for infusion 100ml bottles 0902022A0AAAEAE	Human albumin	Albumin solution	Nutrition and Blood	No data available
Albumin human 4.5% solution for infusion 250ml bottles 0902022A0AAAFAF	Human albumin	Albumin solution	Nutrition and Blood	No data available
Albumin human 4.5% solution for infusion 400ml bottles 0902022A0AAAIAI	Human albumin	Albumin solution	Nutrition and Blood	No data available
Albumin human 4.5% solution for infusion 500ml bottles 0902022A0AAAGAG	Human albumin	Albumin solution	Nutrition and Blood	No data available
Albumin human 4.5% solution for infusion 50ml bottles 0902022A0AAAKAK	Human albumin	Albumin solution	Nutrition and Blood	No data available
Albumin human 5% solution for infusion 100ml bottles 0902022A0AAALAL	Human albumin	Albumin solution	Nutrition and Blood	No data available
Albumin human 5% solution for infusion 250ml bottles 0902022A0AAAMAM	Human albumin	Albumin solution	Nutrition and Blood	No data available
Albumin human 5% solution for infusion 500ml bottles 0902022A0AAANAN	Human albumin	Albumin solution	Nutrition and Blood	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.